Cibc Bancorp Usa Inc. Adaptive Biotechnologies Corp Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 25,328 shares of ADPT stock, worth $358,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,328Holding current value
$358,137% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
284Shares Held
159MCall Options Held
137KPut Options Held
33.3K-
Viking Global Investors LP30MShares$424 Million1.27% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$165 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$159 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.97MShares$84.4 Million0.02% of portfolio
-
Braidwell LP Stamford, CT3.86MShares$54.6 Million2.76% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.02B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...